Paper41622930
[Mechanisms of Exosomes in Lung Cancer Bone Metastasis and Related Clinical Advances].
Yuan Y and 1 other. Zhongguo Fei Ai Za Zhi, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. [Mechanisms of Exosomes in Lung Cancer Bone Metastasis and Related Clinical Advances]. Papers, record 41622930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41622930
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Lung Neoplasms | Major topic |
| Bone Neoplasms | Major topic |
| Humans | |
| Animals | |
| Tumor Microenvironment |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39625368 | FRK exerts oncogenic effects by targeting NQO2 via exosomal miR-9-3p to regulate mitochondrial function. | FASEB J | 2024 | https://conductscience.org/library/papers/39625368 | PubMed |
| 2 | 39494330 | New insights into non-small cell lung cancer bone metastasis: mechanisms and therapies. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/39494330 | PubMed |
| 3 | 38353469 | Exosome inhibition improves response to first-line therapy in small cell lung cancer. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38353469 | PubMed |
| 4 | 33911215 | Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer. | Nat Rev Clin Oncol | 2021 | https://conductscience.org/library/papers/33911215 | PubMed |
| 5 | 32029601 | The biology, function, and biomedical applications of exosomes. | Science | 2020 | https://conductscience.org/library/papers/32029601 | PubMed |
| 6 | 39830759 | Inhibition of miR-9-3p facilitates ferroptosis by activating SAT1/p53 pathway in lung adenocarcinoma. | Transl Lung Cancer Res | 2024 | https://conductscience.org/library/papers/39830759 | PubMed |
| 7 | 38509870 | Hypoxic Exosomal circPLEKHM1-Mediated Crosstalk between Tumor Cells and Macrophages Drives Lung Cancer Metastasis. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38509870 | PubMed |
| 8 | 33837261 | Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/33837261 | PubMed |
| 9 | 32783691 | Serum-Derived Exosomes-Mediated Circular RNA ARHGAP10 Modulates the Progression of Non-Small Cell Lung Cancer Through the miR-638/FAM83F Axis. | Cancer Biother Radiopharm | 2022 | https://conductscience.org/library/papers/32783691 | PubMed |
| 10 | 34298673 | Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298673 | PubMed |
| 11 | 39582078 | [18F]FDG PET/CT performs better than CT in determining the bone biopsy site : randomized controlled clinical trial. | Cancer Imaging | 2024 | https://conductscience.org/library/papers/39582078 | PubMed |
| 12 | 39817679 | Cancer statistics, 2025. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/39817679 | PubMed |
| 13 | 33680573 | Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/33680573 | PubMed |
| 14 | 34215717 | Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34215717 | PubMed |
| 15 | 32446904 | MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway. | Cell Signal | 2020 | https://conductscience.org/library/papers/32446904 | PubMed |
| 16 | 34124049 | Lung Cancer Cell-Derived Exosomal let-7d-5p Down-Regulates OPRM1 to Promote Cancer-Induced Bone Pain. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34124049 | PubMed |
| 17 | 33913604 | Exosomes: Isolation, characterization, and biomedical applications. | Cell Biol Int | 2021 | https://conductscience.org/library/papers/33913604 | PubMed |
| 18 | 35116241 | Transcriptome Sequencing reveals the expressed profiles of mRNA and ncRNAs and regulate network via ceRNA mediated molecular mechanism of lung adenocarcinoma bone metastasis in Xuanwei. | Transl Cancer Res | 2021 | https://conductscience.org/library/papers/35116241 | PubMed |
| 19 | 39262456 | Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (CISD2), involved in lung adenocarcinoma bone metastasis via MYC activation, and associated with tumor immune infiltration. | Transl Cancer Res | 2024 | https://conductscience.org/library/papers/39262456 | PubMed |
| 20 | 32093031 | The Role of miR-21 in Osteoblasts-Osteoclasts Coupling In Vitro. | Cells | 2020 | https://conductscience.org/library/papers/32093031 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41622930
GET https://conductscience.org/api/papers/v1/41622930/references?page=2